EFFICACY AND SAFETY OF USTEKINUMAB THROUGH WEEK 16 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS RANDOMIZED TO USTEKINUMAB: RESULTS FROM THE UNIFI INDUCTION TRIAL

被引：0
|
作者：
Danese, Silvio
Sands, Bruce E.
O'Brien, Christopher D.
Zhang, Hongyan
Johanns, Jewel
Sloan, Sheldon
Izanec, James L.
Szapary, Philippe
Marano, Colleen W.
Leong, Rupert W.
Rowbotham, David
Targan, Stephan R.
Van Assche, Gert A.
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1739
引用
收藏
页码：S1106 / S1106
页数：1
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF INTRAVENOUS USTEKINUMAB RE-INDUCTION THERAPY IN CROHN'S DISEASE PATIENTS WITH SECONDARY LOSS OF RESPONSE TO USTEKINUMAB MAINTENANCE THERAPY: WEEK 16 RESULTS FROM THE POWER TRIAL
    Lee, Scott D.
    Schreiber, Stefan
    Janneke, Christien
    Van der Woude
    Marin-Jimenez, Ignacio
    Wolf, Douglas C.
    Schnoy, Elisabeth
    Salzberg, Bruce
    Busse, Christopher
    Nazar, Maciej
    Langholff, Wayne
    Borghorst, Stephan
    Gasink, Christopher
    Baker, Thomas
    Godwin, Bridget
    Feagan, Brian G.
    GASTROENTEROLOGY, 2023, 164 (06) : S220 - S220
  • [32] Pharmacokinetics and exposure-response relationships of intravenously administered ustekinumab during induction treatment in patients with ulcerative colitis: Results from the UNIFI induction study
    Adedokun, O. J.
    Xu, Z.
    Marano, C.
    O'Brien, C. D.
    Szapary, P.
    Zhang, H.
    Johanns, J.
    Leong, R. W.
    Hisamatsu, T.
    Van Assche, G.
    Danese, S.
    Abreu, M. T.
    Sands, B. E.
    Sandborn, W. J.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S255 - S256
  • [33] Pharmacokinetics and exposure-response relationships of intravenously administered ustekinumab during induction treatment in patients with ulcerative colitis: Results from the UNIFI induction study
    Adedokun, O.
    Xu, Z.
    Marano, C.
    O'Brien, C.
    Szapary, P.
    Zhang, H.
    Johanns, J.
    Leong, R.
    Hisamatsu, T.
    Van Assche, G.
    Danese, S.
    Abreu, M.
    Sands, B.
    Sandborn, W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 147 - 147
  • [34] PHARMACOKINETICS AND EXPOSURE-RESPONSE RELATIONSHIPS OF INTRAVENOUSLY ADMINISTERED USTEKINUMAB DURING INDUCTION TREATMENT IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE UNIFI INDUCTION STUDY
    Adedokun, Omoniyi J.
    Xu, Zhenhua
    Marano, Colleen W.
    O'Brien, Christopher D.
    Szapary, Philippe
    Zhang, Hongyan
    Johanns, Jewel
    Leong, Rupert W.
    Hisamatsu, Tadakazu
    Van Assche, Gert A.
    Danese, Silvio
    Abreu, Maria T.
    Sands, Bruce E.
    Sandborn, William J.
    GASTROENTEROLOGY, 2019, 156 (06) : S1110 - S1110
  • [35] Efficacy in biologic failure and non-biologic-failure populations in a Phase 3 study of ustekinumab in moderate-severe ulcerative colitis: UNIFI
    Sands, B. E.
    Peyrin-Biroulet, L.
    Marano, C.
    O'Brien, C. D.
    Zhang, H.
    Johanns, J.
    Szapary, P.
    Rowbotham, D.
    Leong, R. W.
    Arasaradnam, R. P.
    Danese, S.
    Van Assche, G.
    Targan, S.
    Sandborn, W. J.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S256 - S257
  • [36] EFFICACY IN BIOLOGIC-FAILURE AND NONBIOLOGIC-FAILURE POPULATIONS IN A PHASE 3 STUDY OF USTEKINUMAB IN MODERATE-SEVERE ULCERATIVE COLITIS: UNIFI
    Sands, Bruce E.
    Peyrin-Biroulet, Laurent
    Marano, Colleen W.
    O'Brien, Christopher D.
    Zhang, Hongyan
    Johanns, Jewel
    Szapary, Philippe
    Rowbotham, David
    Leong, Rupert W.
    Arasaradnam, Ramesh
    Danese, Silvio
    Van Assche, Gert A.
    Targan, Stephan R.
    Sandborn, William J.
    GASTROENTEROLOGY, 2019, 156 (06) : S181 - S182
  • [37] Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative Colitis
    Veyrard, Pauline
    Pellet, Gauthier
    Laharie, David
    Nachury, Maria
    Juillerat, Pascal
    Roblin, Xavier
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (05) : 1354 - 1355
  • [38] Association Between Efficacy and Long-Term Outcomes: Four Year Results From the UNIFI Study of Ustekinumab in Ulcerative Colitis
    Peyrin-Biroulet, Laurent
    Leong, Rupert
    Sands, Bruce E.
    Miao, Ye
    Marano, Colleen
    Danese, Silvio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S811 - S811
  • [39] Ustekinumab therapy induced clinically meaningful improvement and remission as measured by the Inflammatory Bowel Disease Questionnaire in patients with moderate to severe ulcerative colitis: Results from the Phase III UNIFI induction and maintenance studies
    Sands, B.
    Han, C.
    Johanns, J.
    Szapary, P.
    Marano, C.
    Leong, R.
    Danese, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 160 - 161
  • [40] Safety and efficacy of ustekinumab in adolescent patients with moderate to severe plaque psoriasis: Results through 1 year of the phase 3 CADMUS trial
    Landells, Ian
    Marano, Collen
    Hsu, Ming-Chun
    Li, Shu
    Eichenfield, Lawrence
    Hoeger, Peter
    Menter, Alan
    Paller, Amy
    Taieb, Alain
    Randazzo, Bruce
    Szapary, Philippe
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB202 - AB202
12345